XOMA Limited (NASDAQ:XOMA)

CAPS Rating: 1 out of 5

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

Recs

0
Player Avatar usubanas (99.43) Submitted: 11/20/2012 11:49:34 PM : Outperform Start Price: $3.04 XOMA Score: +9.43

Nov 7 CC: top line data from EYEGUARD-A study at the end of 2013.
I can wait a year.

Featured Broker Partners


Advertisement